Nycomed's imaging sales double at nine months
This article was originally published in Clinica
Executive Summary
Norwegian healthcare company Hafslund Nycomed, which announced its merger with US-based Ivax in October (see Clinica No 677, p 1), has reported imaging sales of NKr 3,827 million ($617 million), double those of a year earlier, in the first nine months.